Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ibandronic acid 2mg/2ml solution for infusion ampoules
0606020W0AAAAAA
|
Ibandronic acid | Ibandronic acid | Endocrine System | No data available |
|
Ibandronic acid 2mg/2ml solution for infusion vials
0606020W0AAAFAF
|
Ibandronic acid | Ibandronic acid | Endocrine System | No data available |
|
Ibandronic acid 6mg/6ml solution for infusion vials
0606020W0AAACAC
|
Ibandronic acid | Ibandronic acid | Endocrine System | No data available |
|
Ibrance 100mg capsules
0801050CBBBABAB
|
Ibrance | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Ibrance 100mg tablets
0801050CBBBADAD
|
Ibrance | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Ibrance 125mg capsules
0801050CBBBACAC
|
Ibrance | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Ibrance 125mg tablets
0801050CBBBAEAE
|
Ibrance | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Ibrance 75mg capsules
0801050CBBBAAAA
|
Ibrance | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Ibrance 75mg tablets
0801050CBBBAFAF
|
Ibrance | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Ibrutinib 140mg capsules
0801050BSAAAAAA
|
Ibrutinib | Ibrutinib | Malignant Disease and Immunosuppression | No data available |
|
Ibrutinib 140mg tablets
0801050BSAAABAB
|
Ibrutinib | Ibrutinib | Malignant Disease and Immunosuppression | No data available |
|
Ibrutinib 280mg tablets
0801050BSAAACAC
|
Ibrutinib | Ibrutinib | Malignant Disease and Immunosuppression | No data available |
|
Ibrutinib 420mg tablets
0801050BSAAADAD
|
Ibrutinib | Ibrutinib | Malignant Disease and Immunosuppression | No data available |
|
Ibrutinib 560mg tablets
0801050BSAAAEAE
|
Ibrutinib | Ibrutinib | Malignant Disease and Immunosuppression | No data available |
|
Ibucalm Ibuprofen Pain Relief 5% gel
1003020P0BUAAAC
|
Ibucalm (Topical Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuderm 5% gel
1003020P0BTAAAC
|
Ibuderm | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibufem 200mg tablets
1001010J0CHAAAD
|
Ibufem | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibular 200mg tablets
1001010J0DJAAAD
|
Ibular (Ennogen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibular 400mg tablets
1001010J0DJABAE
|
Ibular (Ennogen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuleve 5% Mousse
1003020P0BCAEAF
|
Ibuleve | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuleve 5% spray
1003020P0BCACAD
|
Ibuleve | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuleve Sports 5% gel
1003020P0BCABAC
|
Ibuleve | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibumousse 5%
1003020P0BKAAAF
|
Ibumousse | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 100mg/5ml / Pseudoephedrine 15mg/5ml susp SF
0309020AAAAABAB
|
Ibuprofen/pseudoephedrine hydrochloride | Ibuprofen/pseudoephedrine hydrochloride | Respiratory System | No data available |
|
Ibuprofen 10mg/2ml solution for infusion ampoules
0701011F0AAAAAA
|
Ibuprofen (Neonatal) | Ibuprofen | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.